Dr Janine Lombard

Senior Staff Specialist, Hunter New England Health

Research Programs

Cancer Detection and Therapy

Contact

Co investigator on POEMS study (prevention of early menopause in women with early breast cancer)

International principal investigator representing Australia in ALTTO study – one of the largest adjuvant breast cancer studies in women with Her 2 positive breast cancer

International Principal investigator on TRIO 022 study which confirmed the benefit of adding CDK inhibitors to endocrine therapy for patients with hormone positive breast cancer

Dr Janine Lombard is a Medical Oncologist working in public practice at Calvary Mater Newcastle and at Newcastle Private Oncology.

Janine’s clinical expertise is in the care of patients with gynaecological or breast cancers and she is passionate about improving health outcomes for these individuals.

In addition to clinical work, Janine is involved in clinical and translational research in both gynaecological and breast cancer through her research at Calvary Mater Medical Oncology and via collaboration with HMRI researchers and the University of Newcastle.

She has been a member of the Australia and New Zealand Gynaecology Oncology Group (ANZGOG) since 2007 serving long term on the Ovarian cancer tumor working group and is currently appointed as Chair Elect of ANZGOG’s Uterine Tumour Working Group.

Dr Lombard has also had a long affiliation with Breast Cancer Trials Group (BCT Australia and New Zealand); serving for several years on the BCT Scientific Advisory Panel. In her role at Calvary Mate, she also represents the medial workforce as the current chair of the Medical Staff Council.

HMRI would like to acknowledge the Traditional Custodians of the land on which we work and live, the Awabakal and Worimi peoples, and pay our respects to Elders past and present. We recognise and respect their cultural heritage and beliefs and their continued connection to their land.